These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 7507893

  • 1. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P, Sato H, Sato Y, Locht C.
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [Abstract] [Full Text] [Related]

  • 2. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.
    Abomoelak B, Huygen K, Kremer L, Turneer M, Locht C.
    Infect Immun; 1999 Oct; 67(10):5100-5. PubMed ID: 10496883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG.
    N Engl J Med; 1996 Feb 08; 334(6):341-8. PubMed ID: 8538704
    [Abstract] [Full Text] [Related]

  • 6. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A, Bona G, Canciani G, Pistilli AM, Contu B, Furlan R, Meloni T, Stramare D, Titone L, Rappuoli R.
    J Pediatr; 1995 Aug 08; 127(2):238-43. PubMed ID: 7636648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
    Redhead K, Sesardic D, Yost SE, Attwell AM, Watkins J, Hoy CS, Plumb JE, Corbel MJ.
    Biologicals; 1994 Dec 08; 22(4):339-45. PubMed ID: 7779360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.
    Fairweather NF, Lyness VA, Maskell DJ.
    Infect Immun; 1987 Nov 08; 55(11):2541-5. PubMed ID: 3312002
    [Abstract] [Full Text] [Related]

  • 14. Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes.
    Soria-Guerra RE, Rosales-Mendoza S, Moreno-Fierros L, López-Revilla R, Alpuche-Solís AG.
    Plant Cell Rep; 2011 Mar 08; 30(3):417-24. PubMed ID: 21188384
    [Abstract] [Full Text] [Related]

  • 15. Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli.
    Aminian M, Sivam S, Lee CW, Halperin SA, Lee SF.
    Protein Expr Purif; 2007 Feb 08; 51(2):170-8. PubMed ID: 16950635
    [Abstract] [Full Text] [Related]

  • 16. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.
    Saikh KU, Sesno J, Brandler P, Ulrich RG.
    Vaccine; 1998 Feb 08; 16(9-10):1029-38. PubMed ID: 9682355
    [Abstract] [Full Text] [Related]

  • 17. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
    Patel SS, Wagstaff AJ.
    Drugs; 1996 Aug 08; 52(2):254-75. PubMed ID: 8841742
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.